Thursday, March 26, 2026

Nigeria eases FX rules, lets oil firms retain full export proceeds

Nigeria's central bank has removed a requirement that forced international oil companies to temporarily retain part of their export earnings, allowing them ​to repatriate all proceeds in a move aimed at improving liquidity and ‌confidence in the foreign exchange market.

In a circular dated March 25, the central bank said it had scrapped earlier "cash pooling" requirements that allowed authorised dealer banks to transfer only half of ​oil export proceeds immediately, with the balance held for up to 90 ​days.

Under the new directive, oil companies may repatriate all export earnings ⁠through authorised banks, subject to documentation and monthly reporting, with immediate effect.

The move ​signals further liberalisation of Nigeria’s foreign exchange regime for oil exporters, a key source ​of dollar inflows, though it is unlikely to produce an immediate jump in supply.

The central bank said the move was part of ongoing reforms to “further liberalise and deepen the market in ​line with current market realities,” as it works to stabilise the naira currency ​and attract investment.

For international oil companies, the reform restores greater control over cash-flow management, allowing firms ‌to ⁠decide when and how to deploy export earnings without mandatory holding periods.

Industry executives say freer access to dollar revenues improves treasury efficiency and marginally lowers financial risk in Nigeria’s upstream sector, where confidence over capital mobility remains key.

The change reverses a restriction ​imposed in February 2024 ​amid acute dollar ⁠shortages that pushed the naira to record lows. At that time, the central bank capped immediate transfers of oil export proceeds ​at 50%, with the remainder held locally for 90 days ​in a ⁠bid to shore up dollar liquidity.

That earlier measure formed part of a broader package of reforms following years of foreign exchange strain linked to low oil prices and ⁠the ​COVID-19 shock.

Since then, the central bank has also raised ​open-market rates to attract investors and scrapped caps on foreign-exchange spreads in the interbank market as it ​unwinds controls introduced during periods of stress.

By Isaac Anyaogu, Reuters

Wednesday, March 25, 2026

Nigeria’s TB fight highlights urgent need for early diagnosis



On World Tuberculosis Day, Nigeria faces one of the highest TB burdens globally, with an estimated 510,000 new cases each year. Children are especially vulnerable, often showing symptoms similar to common respiratory infections, making early diagnosis critical. Families like Aisha Peter highlight the human impact behind the statistics, showing that timely treatment can save lives.

Dangote Refinery Boosts Africa Fuel Supply Amid Global Disruptions



Nigeria’s Dangote Refinery is emerging as a key supplier across Africa, ramping up fuel exports just as global energy flows face disruption due to the Iran war. With the plant now running at full capacity, shipments have begun reaching multiple countries, including South Africa, Ivory Coast, Cameroon and Ghana. The move is helping ease regional fuel shortages and highlights Africa’s growing role in stabilising energy supply chains.

Nigeria rolls out locally made armoured carriers as army ramps up defence capabilities


 







The Nigerian Army has taken delivery of a new batch of armoured personnel carriers, combining locally manufactured platforms with foreign-supplied vehicles, in a move that underscores the country’s growing ambitions in defence production and its continued reliance on international partnerships.

More than half a dozen Vanquisher light armoured personnel carriers, produced by the Defence Industries Corporation of Nigeria in collaboration with Vanquish Industries Limited, were delivered alongside dozens of Dagger APCs from French defence firm Arquus.

According to Defence Web, a total of 15 Vanquisher vehicles were formally handed over on March 4, marking what military officials described as a key milestone in Nigeria’s drive toward self-reliance in military hardware.

Built on a modified Toyota Land Cruiser platform and equipped with mounted weapon systems, the vehicles are tailored for Nigeria’s operational terrain, particularly in counter-insurgency missions.

Speaking at the handover, Major General Bamidele Alabi, Chief of Policy and Plans (Army), emphasized that indigenous defence innovation remains critical to achieving combat readiness and operational superiority.

He noted that locally developed platforms such as the Vanquisher are designed to address Nigeria’s unique security challenges while strengthening rapid response capabilities.

Nigeria’s investment in domestic defence manufacturing comes at a time when the country is battling persistent security threats, including insurgency in the northeast and banditry in other regions.

By expanding local production capacity, authorities aim to reduce reliance on imports, cut costs, and retain capital within the economy.

At the same time, the acquisition of Dagger APCs from France highlights Abuja’s pragmatic approach, combining homegrown innovation with international support to quickly scale its military capabilities.

The 4×4 Dagger weighs 5.5 tonnes and is designed for mobility in urban and complex environments. Powered by a 170 hp diesel engine, it can reach speeds of up to 110 km/h with a range of 800 km.

It carries two crew members and six troops, and can be fitted with either a pintle-mounted or remotely operated 7.62 mm machine gun. Over 1,200 units have been produced for countries including France, Chile, Romania, and Togo

Director-General of DICON, Major General BI Alaya, credited President Bola Ahmed Tinubu for supporting the expansion of Nigeria’s military-industrial base, describing the development as central to national sovereignty and long-term security.

Analysts say Nigeria’s dual-track strategy which involves building local manufacturing while maintaining foreign defence ties, positions it as an emerging player in Africa’s defence industry.

If sustained, this approach could not only strengthen national security but also open opportunities for Nigeria to supply military hardware to other African nations facing similar threats.

By Solomon Ekanem, Business Insider Africa

Tuesday, March 24, 2026

Demand surges in Nigeria for new HIV prevention injection ahead of rollout

Interest is rising across Nigeria in a new long-acting HIV prevention injection, even before its full nationwide rollout.

Health workers and community organisations say people are actively seeking access to Lenacapavir, a twice-yearly injectable drug designed to prevent HIV infection. The treatment, developed by Gilead Sciences and endorsed by the World Health Organisation in 2025, offers an alternative to daily preventive pills.

Nigeria’s government has begun introducing the drug in selected pilot states, with an official launch expected this week. Authorities say more than 11,000 doses have already been delivered, out of a planned 52,000.

The rollout will initially cover several states, including Lagos, Kano and Benue, as well as the federal capital, Abuja. The injection will be administered free of charge at designated public health facilities, not through private pharmacies.


High demand-and confusion

Civil society groups and frontline health workers report strong demand, particularly among people at higher risk of HIV exposure, including couples where one partner is HIV-positive.

However, some organisations say there is widespread misunderstanding about the drug. Many people believe it can cure HIV, when in fact it is only designed to prevent infection in those who are HIV-negative.

“People are asking for it even before it becomes widely available, but some think it’s a treatment rather than prevention,” one health worker said.

Nigeria has one of the largest HIV burdens globally, with around two million people living with the virus, according to recent estimates.


Caution from experts

Medical professionals have welcomed the innovation but stress the need for careful rollout. Pharmacists and regulators say the drug must undergo strict safety and quality checks before broader distribution.

Authorities have also issued guidance on its use, noting that it is currently approved only for non-pregnant individuals.

Despite these concerns, public health advocates say early adoption could help reduce new infections, especially among high-risk groups, if awareness improves and access expands nationwide.